Screening of Glypican-6 Expression in Benign, Primary and Metastatic Colon Cancers.

Yousef M Al-SarairehFatemah Ofo AlshammariAhmed M M YoussefSameeh Al-SarayrehYahya M Al-SarayraEmad AborajoohJehad Al-ShuneigatHamzeh M Alrawashdeh

Published in: Clinical Medicine Insights. Oncology (2021)

Selective expression of glypican-6 may establish a basis for potential use as a tissue biomarker or as a novel therapeutic target in treatment of colon cancer.

Keyphrases

poor prognosis
small cell lung cancer
squamous cell carcinoma
binding protein
long non coding rna
risk assessment
human health
climate change
childhood cancer